Peptide storage and stability: what actually degrades it
Lyophilized peptide lasts months; reconstituted degrades in days to weeks. The in-use windows to borrow, the BAC-water question, and how to read a CoA.

For research and educational purposes only. Not medical advice.
Category: Peptides. 9 min read. By pepSmart Editorial. . .
Key takeaways
- Lyophilized (freeze-dried) peptide is stable for months to years; reconstituted peptide degrades much faster because hydrolysis and the other chemical pathways run in water, not in a dry solid .
- Borrow the FDA-labeled in-use windows: an in-use Ozempic pen lasts up to 56 days at room temperature or refrigerated, the multi-dose Wegovy FlexTouch pen the same 56 days, and a single-dose Mounjaro or Zepbound pen or vial up to 21 days before you discard it .
- Peptides degrade by several routes: hydrolysis (worse with heat and pH extremes), deamidation (Asn and Gln residues), oxidation (Met, Cys, Trp, Tyr, His), aggregation, and disulfide scrambling .
- Bacteriostatic water for injection is sterile water plus 0.9% (9 mg/mL) benzyl alcohol as a preservative, supplied in a multiple-dose container; that preservative is what lets you re-enter a reconstituted vial across the standard 28-day multi-dose window .
- A meaningful certificate of analysis is lot-specific: purity by HPLC (commonly 95 percent or higher), identity confirmed by mass spectrometry, and a measured endotoxin level. A generic or missing CoA is worth less than it looks.
Skip to:
- Lyophilized vs. reconstituted: water starts the clock
- The degradation chemistry that shortens the window
- Diluents: bacteriostatic water, sterile water, and pH
- Light, temperature, and freeze-thaw cycles
- Named in-use windows from approved labels
- Compounded cold-chain reality
- How to read a certificate of analysis (CoA)
- What the published stability literature actually shows
- The bottom line on storing peptides
Lyophilized vs. reconstituted: water starts the clock
A lyophilized peptide is a freeze-dried solid. With the water gone, hydrolysis (the dominant chemical breakdown route for peptide bonds in solution) slows to a crawl, which is why a powder keeps for months to years . Reconstitute it and that same peptide is now sitting in water, and its shelf life shortens to days or weeks. That gap is why parenteral peptide labels quote a long shelf life for the powder and a much shorter in-use window after mixing.
FDA-approved peptide labels make the pattern concrete. The GLP-1 analogs semaglutide and tirzepatide carry refrigerated storage before first use and an in-use window measured in weeks once the pen is pierced . A compounded vial does not inherit any of those validated numbers, and the FDA has flagged dosing-error harm with compounded semaglutide, largely from confusion between milligrams, milliliters, and 'units' . The storage lesson is the same one: a compounded preparation follows the pharmacy's beyond-use date, not a branded pen's clock.
The degradation chemistry that shortens the window
Peptides break down by several distinct chemical and physical pathways, each with its own sensitivity to storage conditions :
- Hydrolysis: the peptide bond cleaves in the presence of water, and the rate climbs with temperature and at pH extremes. This is the dominant pathway for a reconstituted peptide, and it is exactly the reaction the dry powder avoids.
- Deamidation: asparagine and glutamine residues lose their amide group and become aspartate and glutamate. The mass change is tiny, but it can shift receptor binding and nudge the molecule toward aggregation.
- Oxidation: methionine, cysteine, tryptophan, tyrosine, and histidine residues oxidize in the presence of air or light. Methionine oxidation is the most common, and trace transition metals (iron, copper) accelerate it.
- Aggregation: peptide molecules physically clump together, driven by hydrophobic interactions, surface adsorption, or freeze-thaw stress. Aggregates can be immunogenic and pull active monomer out of solution.
- Disulfide scrambling: peptides with multiple cysteines (insulin, oxytocin, vasopressin) can reshuffle their disulfide bonds in solution into misfolded, inactive species.
Diluents: bacteriostatic water, sterile water, and pH
Bacteriostatic water for injection is sterile water with 0.9% (9 mg/mL) benzyl alcohol added as a preservative, supplied in a multiple-dose container from which repeated withdrawals may be made . The benzyl alcohol holds back the bacteria a needle can carry in, which is what makes repeated draws from one vial reasonable. Sterile water for injection has no preservative and is meant for single use. The label also carries a hard exception: bacteriostatic water is not for neonates, because benzyl alcohol is toxic to them .
Some peptides are pH-sensitive in solution. Aggregation, deamidation, and oxidation rates all move with pH and ionic strength , which is why approved peptide products fix the diluent identity and concentration on the label instead of leaving it to the user.
Light, temperature, and freeze-thaw cycles
- Light: photo-oxidation of methionine, tryptophan, tyrosine, and histidine residues is well characterized in peptide chemistry . Amber vials and opaque shipping help, and most labeled peptide products tell you to protect the drug from light.
- Temperature: most reconstituted peptides degrade faster at room temperature than in the fridge. Approved products specify 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius) for storage, with brief room-temperature excursions (often up to 30 degrees Celsius) allowed inside the labeled in-use window.
- Freeze-thaw: repeatedly freezing and thawing a solution drives aggregation. A dry lyophilized powder is far more forgiving because there is no liquid water to nucleate ice damage. The Wegovy and Ozempic labels flatly prohibit freezing the pen, and say not to use it if it has been frozen .
- Agitation: shaking a liquid peptide creates air-water interfaces that promote denaturation and aggregation. Most labels ask for gentle inversion, not shaking, during reconstitution.
Named in-use windows from approved labels
- Wegovy (semaglutide): store refrigerated at 2 to 8 C. Read the two formats separately. A single-dose pen or syringe is discarded straight after use, and its 28-day allowance at 8 to 30 C is a before-use window that runs prior to cap removal, not an in-use clock. The multi-dose Wegovy FlexTouch pen is the one with a real in-use window, 56 days at 15 to 30 C or refrigerated after first use .
- Ozempic (semaglutide): store refrigerated at 2 to 8 C before first use; after first use the pen is good for up to 56 days at room temperature (15 to 30 C) or refrigerated .
- Mounjaro / Zepbound (tirzepatide): refrigerated at 2 to 8 C; a single-dose pen or vial holds a running total of 21 days at room temperature (up to 30 C) before you discard it, and moving it back to the fridge does not restart that count . The multi-dose tirzepatide vial and KwikPen run on a separate 30-day clock .
- Egrifta WR (tesamorelin): a lyophilized peptide reconstituted with bacteriostatic water; the mixed solution is stored at room temperature (20 to 25 C) and discarded 7 days after mixing, and is not frozen . It is a clean example of how fast the in-use clock runs once water is added.
- Reconstituted research peptides (BPC-157, TB-500, ipamorelin): no FDA label exists, so there is no validated in-use number. The defensible ceiling is the multi-dose vial rule, discard within about 28 days of first needle entry under USP Chapter 797 , with the honest caveat that the peptide itself can lose potency sooner, so refrigerate it and go by the earliest limit. Unmixed lyophilized powder lasts far longer, months to years, refrigerated or frozen.
Compounded cold-chain reality
Compounded peptide preparations from 503A pharmacies usually ship in insulated boxes with cold packs by overnight courier. The temperature trace from pharmacy to user runs through several handoffs (pharmacy to courier, courier to local hub, hub to delivery vehicle, vehicle to doorstep), and excursions above the labeled refrigerated range are common in summer climates and on packages left at the door before anyone gets to them.
Some 503A pharmacies drop a temperature-indicator strip in the box. Most do not, so you often have no way to confirm the cold chain held end to end. The practical move you can actually make: refrigerate the vial the moment it arrives, and before drawing, look at the solution. It should be clear. If it is cloudy, discolored, has particles, or you know it froze, do not use it.
How to read a certificate of analysis (CoA)
A certificate of analysis from a peptide manufacturer typically reports peptide purity (HPLC area percent), peptide content (mass spec or amino acid analysis), water content (Karl Fischer), residual TFA if the peptide was made with it, endotoxin level, and identity by mass spec. An FDA-approved drug product goes well past a CoA into batch-release testing, sterility, and stability-indicating assays.
What matters for a buyer is that every one of those numbers is tied to the specific lot in hand: purity of 95 percent or higher by HPLC, identity confirmed by mass spec at the expected molecular weight, and a low measured endotoxin level. A CoA with no batch-specific data, or a vendor who cannot produce one at all, is offering less assurance than the paperwork implies. The full walkthrough of reading a peptide certificate of analysis covers how the fakes fall apart.
What the published stability literature actually shows
For approved products, the chemistry, manufacturing, and controls data behind these windows sit in the FDA review documents in Drugs@FDA . For research peptides, public stability data usually stop at the manufacturer's certificate of analysis, so a PubMed search for the specific peptide plus 'stability' is the honest starting point .
The GLP-1 stability literature is deeper than anything published on a gray-market research peptide. Semaglutide, for instance, has peer-reviewed work showing it slowly aggregates into spherical micelles and a small population of short needle-shaped fibrils in aqueous solution , the kind of physical instability that formulation and cold storage exist to hold off. For most research peptides, no comparable published work exists, which is the real gap between a labeled drug and a vial off a website.
The bottom line on storing peptides
Lyophilized powder is the stable form; water is what starts the clock. When there is no primary stability data for your exact peptide, the labeled in-use windows from approved products are the best real-world reference you have, and treating a reconstituted vial like an in-use pen (cold, dark, never frozen, used inside the window) is the safe default. A compounded vial does not inherit any branded number, so the beyond-use date the pharmacy printed is the one that counts.
For research and educational purposes only. Not medical advice.
pepSmart has not commissioned independent clinical review of this article.
More on how we write and source these pieces: Editorial process and contributor disclosure and Sourcing posture.
Spot an error? Email corrections via /about.
Sources: 12 entries, all primary canon (FDA drug labels via DailyMed, FDA guidance, and peer-reviewed pharmaceutical-science literature), last reviewed 2026-07-08.
Related tools
- Tirzepatide dose calculator - Run tirzepatide-focused vial draw math.
- GLP-1 conversion calculator - Convert a GLP-1 mg dose to U-100 units and ml.
- GLP-1 ramp planner - Preview a linear educational dose-step table.
- Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
- PK simulator overview - Public overview of the Pro pharmacokinetic simulator.
- Semaglutide dose calculator - Run semaglutide-focused vial draw math.
References
- [1] OZEMPIC (semaglutide) injection prescribing information, Section 16 How Supplied/Storage and Handling (in-use pen up to 56 days at room temperature 15-30 C or refrigerated; do not freeze) (U.S. FDA via DailyMed)
- [2] WEGOVY (semaglutide) injection and tablets, Novo Nordisk US prescribing information revised 6/2026, Section 16 How Supplied/Storage and Handling: store at 2 to 8 C; a single-dose pen or syringe may be kept at 8 to 30 C for up to 28 days prior to cap removal and is discarded after use; the single-patient-use WEGOVY FlexTouch pen may be stored 56 days at 15 to 30 C or refrigerated after first use; do not freeze WEGOVY and do not use it if it has been frozen (U.S. FDA via DailyMed)
- [3] MOUNJARO (tirzepatide) injection prescribing information, Section 16 How Supplied/Storage and Handling (single-dose pen or vial up to 21 days at room temperature; multi-dose vial and KwikPen up to 30 days) (U.S. FDA via DailyMed)
- [4] ZEPBOUND (tirzepatide) injection prescribing information, Section 16 How Supplied/Storage and Handling (single-dose pen or vial up to 21 days at room temperature; do not return to the refrigerator once out) (U.S. FDA via DailyMed)
- [5] EGRIFTA WR (tesamorelin) for injection prescribing information (reconstitute with bacteriostatic water; store the mixed solution at 20-25 C and discard 7 days after mixing; do not freeze) (U.S. FDA via DailyMed)
- [6] BACTERIOSTATIC WATER for injection, USP prescribing information (0.9% / 9 mg/mL benzyl alcohol as a bacteriostatic preservative; multiple-dose container; NOT FOR USE IN NEONATES) (U.S. FDA via DailyMed)
- [7] FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products (U.S. FDA)
- [8] Drugs@FDA: FDA-approved drugs, chemistry/manufacturing/controls review documents (U.S. FDA (accessdata))
- [9] Manning MC et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010 (chemical and physical degradation pathways: deamidation, oxidation, hydrolysis, aggregation) (Pharmaceutical Research via PubMed (PMID 20143256))
- [10] Hamley IW et al. Semaglutide Aggregates into Oligomeric Micelles and Short Fibrils in Aqueous Solution. Biomacromolecules. 2025 (PMC12152837) (Biomacromolecules via PubMed Central)
- [11] Multidose injection vials: USP Chapter 797 28-day discard after opening or needle access, and disinfection of the rubber diaphragm before withdrawal (hospital practice study) (PubMed Central (PMC6149120))
- [12] PubMed search: peptide stability formulation (PubMed)
For research and educational purposes only. Not medical advice.